Skip to content

Efficacy and safety of ciprofol in anesthesia during gynecological day surgery

Efficacy and safety of ciprofol in anesthesia during gynecological day surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053444
Enrollment
Unknown
Registered
2021-11-21
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

experimental group:ciprofol injection 0.2ml/Kg
control group:propofol injection 0.2 mL /Kg

Sponsors

Weifang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. 200 patients who underwent hysteroscopy, cervical conization or other gynecological day surgery in our hospital from January 2022 to June 2022; 2. Females aged 18 to 64 years; 3. ASA classification 1-2; 4. Those who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to soybeans and related drugs; 2. Pregnant women, lactating women; 3. Those who cannot establish venous access at the wrist; 4. The operation time is less than 10 minutes or more than 45 minutes; 5. Patients with missing intraoperative and follow-up data.

Design outcomes

Primary

MeasureTime frame
Anesthesia induction success rate;Time of loss of consciousness;

Secondary

MeasureTime frame
Dosage of narcotic drugs;Time of recovery;Stay in hospital for observation;

Countries

China

Contacts

Public ContactJi Fanceng

Weifang people's Hospital

jifanceng@163.com+86 13563698838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026